Vodobatinib (K-0706) is a small molecule which inhibits c-Abl kinase. Its mechanism is focused on inhibiting c-Abl to mitigate neuronal damage and slow the progression of Parkinson’s disease by blocking the effects of harmful signaling in neurons.
Discover our Products
Science-based and high-quality devices
